Opus Genetics, Inc. (IRD) Tops Q2 EPS by 2c
Opus Genetics, Inc. (NASDAQ: IRD) reported Q2 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Opus Genetics, Inc. (IRD) click here.
Opus Genetics, Inc. (NASDAQ: IRD) reported Q2 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Opus Genetics, Inc. (IRD) click here.